PDL BioPharma, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 09/01/2020   Download
SEC Document
SEC Filing
Following stockholder approval of the Declassification Amendment, the Board also approved the Company’s Fourth Amended and Restated Bylaws (the “Amended Bylaws”) making technical and conforming amendments to Sections 2, 3 and 4 of Article III of the Company’s Third Amended and Restated Bylaws. The Amended Bylaws became effective upon filing of the Declassification Amendment with the Delaware Secretary of State on August 26, 2020.